the effect of atorvastatin treatment duration on oxidative stress markers and lipid profile in patients with coronary artery diseases: a case series study

Background:the major aim of this study was evaluating the effect of atorvastatin treatment on thiobarbituric acid reactive substances (tbars), ferric reducing the ability of plasma (frap), small dense low-density lipoprotein cholesterol (sdldl) and lipid profile in coronary artery disease (cad) patients.methods:this study was carried out on 83 patients with angiographically proven coronary artery stenosis (52 men and 31 women) at shahid madani hospital, khorramabad, iran, in 2015. the patients were divided into the 3 groups. 27 patients were classified statins consumption less than 6 days, 28 patients for 6 to 90 days, and 28 patients for more than 90 days. the level of sdldl, lipid profile, tbars and frap were assayed.results:frap levels of patients that received atorvastatin for more than 90 days (832 ± 101) were significantly elevated (p = 0.01) compared to the patients received atorvastatin less than 6 days (688 ± 75), whereas the levels of tbars diminished significantly (p = 0.04). also, the levels of total cholesterol (tc) and ldl-c were significantly decreased after 3 months of atorvastatin receiving (158 as compared to patients that consumed atorvastatin less than 6 days), (p = 0.02 and 0.03, respectively). the level of sdldl was slightly increased with long-time consumption of atorvastatin (37 ± 14) in patients in comparison with patients that received atorvastatin less than 6 days (32 ± 15) (p = 0.06), but was not significant.conclusion:the serum level of tbars decreased and the serum level of frap increased in patients with long-time receiving atorvastatin. therefore, atorvastatin contributes to the lowering oxidative stress in these patients.